Document Detail

Mannose-binding lectin deficiency is associated with smaller infarction size and favorable outcome in ischemic stroke patients.
MedLine Citation:
PMID:  21712986     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: The Mannose-binding lectin (MBL) pathway of complement plays a pivotal role in the pathogenesis of ischemia/reperfusion (I/R) injury after experimental ischemic stroke. As comparable data in human ischemic stroke are limited, we investigated in more detail the association of MBL deficiency with infarction volume and functional outcome in a large cohort of patients receiving intravenous thrombolysis or conservative treatment.
METHODOLOGY/PRINCIPAL FINDINGS: In a post hoc analysis of a prospective cohort study, admission MBL concentrations were determined in 353 consecutive patients with an acute ischemic stroke of whom 287 and 66 patients received conservative and thrombolytic treatment, respectively. Stroke severity, infarction volume, and functional outcome were studied in relation to MBL concentrations at presentation to the emergency department. MBL levels on admission were not influenced by the time from symptom onset to presentation (p = 0.53). In the conservative treatment group patients with mild strokes at presentation, small infarction volumes or favorable outcomes after three months demonstrated 1.5 to 2.6-fold lower median MBL levels (p = 0.025, p = 0.0027 and p = 0.046, respectively) compared to patients with more severe strokes. Moreover, MBL deficient patients (<100 ng/ml) were subject to a considerably decreased risk of an unfavorable outcome three months after ischemic stroke (adjusted odds ratio 0.38, p<0.05) and showed smaller lesion volumes (mean size 0.6 vs. 18.4 ml, p = 0.0025). In contrast, no association of MBL concentration with infarction volume or functional outcome was found in the thrombolysis group. However, the small sample size limits the significance of this observation.
CONCLUSIONS: MBL deficiency is associated with smaller cerebral infarcts and favorable outcome in patients receiving conservative treatment. Our data suggest an important role of the lectin pathway in the pathophysiology of cerebral I/R injury and might pave the way for new therapeutic interventions.
Michael Osthoff; Mira Katan; Felix Fluri; Philipp Schuetz; Roland Bingisser; Ludwig Kappos; Andreas J Steck; Stefan T Engelter; Beat Mueller; Mirjam Christ-Crain; Marten Trendelenburg
Related Documents :
11585856 - Clinical impact of combination of scatter, attenuation correction, and depth-dependent ...
1144756 - The combined use of gated cardiac blood pool scanning and myocardial imaging with posta...
8814716 - The value of tc-99m mibi spect during isosorbide dinitrate infusion in assessment of vi...
9741506 - Significance of rest technetium-99m sestamibi imaging for the prediction of improvement...
22772366 - Value of cardiovascular mr in diagnosing left ventricular non-compaction cardiomyopathy...
15315176 - Detection of left ventricular regional relaxation abnormalities in patients with hypert...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2011-06-21
Journal Detail:
Title:  PloS one     Volume:  6     ISSN:  1932-6203     ISO Abbreviation:  PLoS ONE     Publication Date:  2011  
Date Detail:
Created Date:  2011-06-29     Completed Date:  2011-11-21     Revised Date:  2013-06-28    
Medline Journal Info:
Nlm Unique ID:  101285081     Medline TA:  PLoS One     Country:  United States    
Other Details:
Languages:  eng     Pagination:  e21338     Citation Subset:  IM    
Laboratory of Clinical Immunology, Department of Biomedicine and Clinic for Internal Medicine, University Hospital Basel, Basel, Switzerland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Brain Ischemia / pathology*,  physiopathology,  therapy
Cohort Studies
Complement Pathway, Mannose-Binding Lectin / physiology
Mannose-Binding Lectin / blood,  deficiency*
Middle Aged
Prospective Studies
Reperfusion Injury / pathology*,  physiopathology
Stroke / pathology*,  physiopathology,  therapy
Thrombolytic Therapy
Treatment Outcome
Reg. No./Substance:
0/Mannose-Binding Lectin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A micro RNA processing defect in rapidly progressing idiopathic pulmonary fibrosis.
Next Document:  Classification of first-episode schizophrenia patients and healthy subjects by automated MRI measure...